Bone Therapeutics's total assets for Q2 2024 were €9.40M, a decrease of -1.71% from the previous quarter. GB:0R55 total liabilities were €29.80M for the fiscal quarter, a -7.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.